Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study
- DOI
- 10.1177/13524585251330085
- Published
- 2025-04-18
- Container
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/13524585251330085,
title = {Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study},
author = {Robert J Fox and Stanley Cohan and Yang Mao-Draayer and Bianca Weinstock-Guttman and Linda-Ali Cruz and Sophie Arnould and Gina Mavrikis Cox and Amit Bar-Or},
year = {2025},
journal = {Multiple Sclerosis Journal},
doi = {10.1177/13524585251330085},
url = {https://doi.org/10.1177/13524585251330085}
}RIS
TY - JOUR TI - Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study AU - Robert J Fox AU - Stanley Cohan AU - Yang Mao-Draayer AU - Bianca Weinstock-Guttman AU - Linda-Ali Cruz AU - Sophie Arnould AU - Gina Mavrikis Cox AU - Amit Bar-Or PY - 2025 JO - Multiple Sclerosis Journal DO - 10.1177/13524585251330085 UR - https://doi.org/10.1177/13524585251330085 ER -
APA
Fox, R. J., Cohan, S., Mao-Draayer, Y., Weinstock-Guttman, B., Cruz, L., Arnould, S., Cox, G. M., & Bar-Or, A. (2025). Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585251330085
Source records
- crossref · retrieved 2026-09-26T15:23:09.824Z